Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Kairos Pharma, Ltd. (KAPA) had Pre-Tax Income of $-1.42M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
-- |
|
$-1.42M |
|
-- |
|
-- |
|
$1.46M |
|
$-1.46M |
|
$0.03M |
|
|
Pre-Tax Income |
$-1.42M |
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.42M |
|
$-1.46M |
|
$-0.12M |
|
17.21M |
|
17.21M |
|
$-0.08 |
|
$-0.08 |
|
| Balance Sheet Financials | |
$4.84M |
|
-- |
|
$1.83M |
|
$6.67M |
|
$0.68M |
|
-- |
|
-- |
|
$0.68M |
|
$6.00M |
|
$5.86M |
|
$6.00M |
|
17.74M |
|
| Cash Flow Statement Financials | |
$-1.52M |
|
-- |
|
$3.28M |
|
$1.27M |
|
$3.03M |
|
$1.76M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.16 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-1.52M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-23.71% |
|
-24.29% |
|
-21.31% |
|
-23.71% |
|
$0.34 |
|
$-0.09 |
|
$-0.09 |
|